Baloxavir

Publication Details

CASRN: 1985605-59-1

image 336270137 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the use of baloxavir marboxil during breastfeeding. Because baloxavir is 93% bound to plasma proteins, the amount in milk is likely to be low. If baloxavir is required by the mother, it is not a reason to discontinue breastfeeding, but an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Oseltamivir, Zanamivir

Substance Identification

Substance Name

Baloxavir

CAS Registry Number

1985605-59-1

Drug Class

Breast Feeding

Lactation

Milk, Human

Antiviral Agents

Enzyme Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.